Literature DB >> 623751

Interferon-mediated effect on ribosomal RNA metabolism.

L E Maroun.   

Abstract

Ribosomal RNA (rRNA) has been shown to be involved in the binding of bacterial messenger RNA (mRNA) and an analogous 18 S rRNA.mRNA complex has been reported in eukaryotic systems. Thus, qualitative changes in host rRNA may be involved in the development of the interferon mediated antiviral state, a process thought to involve the inability of host ribosomes to bind and recognize viral mRNA. Data are reported which suggest that trisomy 21 human fibroblasts respond to human interferon with a marked reduction in cytoplasmic rRNA. [3H]Uridine was used to radioactively label the polysomal RNAs for 24 h beginning 12 h after interferon addition. Subsequent sucrose gradient analysis of the phenol or SDS-extracted RNA revealed that the reduction in radioactive rRNA was nearly complete for the 28 S rRNA. In contrast, considerable residual uridine incorporation was found in the 18 S rRNA species. Corollary data suggesting a net increase in mRNA synthesis and a net decrease in protein synthesis are reported.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623751     DOI: 10.1016/0005-2787(78)90038-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Interferon effect on ribosomal ribonucleic acid related to chromosome 21 ploidy.

Authors:  L E Maroun
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

2.  Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.

Authors:  D H Wreschner; T C James; R H Silverman; I M Kerr
Journal:  Nucleic Acids Res       Date:  1981-04-10       Impact factor: 16.971

3.  Trisomy 21 consistently activates the interferon response.

Authors:  Kelly D Sullivan; Hannah C Lewis; Amanda A Hill; Ahwan Pandey; Leisa P Jackson; Joseph M Cabral; Keith P Smith; L Alexander Liggett; Eliana B Gomez; Matthew D Galbraith; James DeGregori; Joaquín M Espinosa
Journal:  Elife       Date:  2016-07-29       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.